Mustang BIO, Inc.

Biotechnology • Healthcare • Waltham, MA, United States • MBIO (NCM)

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases. It develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-101, an IL13Ra2 CAR T cell program for glioblastoma; and MB-108 for the treatment of herpes simplex virus-1 oncolytic virus C134. The company was incorporated in 2015 and is headquartered in Waltham, Massachusetts.

781 652 4500 95 Sawyer Road, Waltham, MA 02453, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Mustang Bio stock soars after FDA grants orphan drug designation - Investing.com

Investing.com • Jul 7

Mustang Bio Stock Surges: Time to Reconsider? - StocksToTrade

StocksToTrade • Jul 7

Mustang Bio’s Stock Soars: What’s Driving the Surge? - timothysykes.com

timothysykes.com • Jul 9

Mustang Bio Shareholders Approve Equity Plans and Directors - TipRanks

TipRanks • Dec 23

Mustang Bio closes Worcester facility, moves HQ to Waltham after reverse stock split - Worcester Business Journal

Worcester Business Journal • Feb 28

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has MUSTANG BIO, INC. had layoffs?

No layoff events have been recorded for MUSTANG BIO, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does MUSTANG BIO, INC. have?

MUSTANG BIO, INC. has approximately 6 employees.

What industry is MUSTANG BIO, INC. in?

MUSTANG BIO, INC. operates in the Biotechnology industry, within the Healthcare sector.

Is MUSTANG BIO, INC. a publicly traded company?

Yes, MUSTANG BIO, INC. is publicly traded under the ticker symbol MBIO on the NCM. The company has a market capitalization of approximately $0.01 billion.

Where is MUSTANG BIO, INC. headquartered?

MUSTANG BIO, INC. is headquartered in Waltham, MA, United States at 95 Sawyer Road, Waltham, MA 02453, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.